Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...
Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...
Professor Chung Seung-il, Department of Urology, Hwasun Chonnam National University Hospital. /Photo provided by=Hwasun ...
Millions of women experience recurring UTI symptoms, but what if the cause is not a bacterial infection? Doctors explain why ...
Pyxis Oncology shifts focus to MICVO after a downgrade and pipeline setback. Click here to read more of this analysis of the ...
A urinary tract infection occurs when bacteria enter and multiply in the urinary system, which includes the bladder and the ...
Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...
In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
Discover how Florida Urology Partners utilizes advanced urologic surgery and personalized care to deliver groundbreaking ...
A DRUG used to treat tapeworms could end women’s suffering from endometriosis, research has suggested. It is estimated that ...
Sometimes a seemingly minor accident can result in injuries that may not be immediately apparent, especially to the head, ...
The International Menopause Society has chosen “Chronic Pain at Midlife” as its 2026 theme, drawing attention to an issue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results